Aileron Therapeutics Statistics

Total Valuation

ALRN has a market cap or net worth of $59.59 million. The enterprise value is $47.52 million.

Market Cap	59.59M
Enterprise Value	47.52M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, after market close.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

ALRN has 21.59 million shares outstanding. The number of shares has increased by 82.81% in one year.

Shares Outstanding	21.59M
Shares Change (YoY)	+82.81%
Shares Change (QoQ)	+73.99%
Owned by Insiders (%)	0.63%
Owned by Institutions (%)	23.28%
Float	19.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.65
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with zero debt.

Current Ratio	2.82
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.80% and return on invested capital (ROIC) is -20.22%.

Return on Equity (ROE)	-33.80%
Return on Assets (ROA)	-31.10%
Return on Capital (ROIC)	-20.22%
Revenue Per Employee	n/a
Profits Per Employee	-$1.20M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.19% in the last 52 weeks. The beta is 2.10, so ALRN's price volatility has been higher than the market average.

Beta (5Y)	2.10
52-Week Price Change	+46.19%
50-Day Moving Average	3.60
200-Day Moving Average	3.48
Relative Strength Index (RSI)	25.44
Average Volume (20 Days)	90,574

Short Selling Information

The latest short interest is 140,356, so 0.65% of the outstanding shares have been sold short.

Short Interest	140,356
Short Previous Month	239,233
Short % of Shares Out	0.65%
Short % of Float	0.71%
Short Ratio (days to cover)	3.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-18.47M
Pretax Income	-18.07M
Net Income	-18.07M
EBITDA	-17.93M
EBIT	-18.07M
Earnings Per Share (EPS)	-$3.22

Full Income Statement

Balance Sheet

The company has $12.07 million in cash and no debt, giving a net cash position of $12.07 million or $0.56 per share.

Cash & Cash Equivalents	12.07M
Total Debt	n/a
Net Cash	12.07M
Net Cash Per Share	$0.56
Equity (Book Value)	91.33M
Book Value Per Share	4.23
Working Capital	8.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.42 million and capital expenditures $42,000, giving a free cash flow of -$20.38 million.

Operating Cash Flow	-20.42M
Capital Expenditures	42,000
Free Cash Flow	-20.38M
FCF Per Share	-$2.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-82.81%
Shareholder Yield	-82.81%
Earnings Yield	-30.32%
FCF Yield	-34.20%

Analyst Forecast

The average price target for ALRN is $19.00, which is 588.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	588.41%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.19%

Stock Forecasts

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a